1.0Association pour la Recherche sur les Séquelles de la Radiothérapiehttps://arser.org/enrich600338<blockquote class="wp-embedded-content" data-secret="0MfW902kGT"><a href="https://arser.org/en/dernieres-nouvelles/">LATEST NEWS</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://arser.org/en/dernieres-nouvelles/embed/#?secret=0MfW902kGT" width="600" height="338" title="“LATEST NEWS” — Association pour la Recherche sur les Séquelles de la Radiothérapie" data-secret="0MfW902kGT" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); //# sourceURL=https://arser.org/wp-includes/js/wp-embed.min.js </script> URGENT MEDICATION OUTAGE: Pentoxifylline, the medicinal pillar of the PENTOCLO triad, has no longer been marketed in France for several months, but remains available abroad (Switzerland, Spain, England, USA, etc.). The current alternatives would be: via ARSER, to make PENTOXIFYLLINE available to you (contact us) OR to offer a therapeutic alternative by substitution with a … Continue reading ""